| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Jack W Callicutt is Chief Financial Officer at GALT. From April 2018 to January 2026, the filings on record show 2 open-market purchases and 12 sales. Jack W Callicutt's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $26K at current prices.
Our model assigns Jack W Callicutt a strong insider score of 71/100, based on 12 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +3.2%.
The GALT filings lean toward selling, a net 623,896 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2018 | GALT Galectin Therapeutics Inc | Chief Financial Officer | Sale+OE | 9,294 | $7.01 | $65,166.74 | -88.1% | |
| Jun 11, 2018 | GALT Galectin Therapeutics Inc | Chief Financial Officer | Sale+OE | 120,000 | $5.85 | $702,500.00 | -99.0% | |
| May 31, 2018 | GALT Galectin Therapeutics Inc | Chief Financial Officer | Sale+OE | 46,651 | $5.00 | $233,255.00 | -97.4% | |
| Apr 4, 2018 | GALT Galectin Therapeutics Inc | Chief Financial Officer | Sale+OE | 3,349 | $5.00 | $16,745.00 | -72.7% |